Literature DB >> 6101347

Limitations of presynaptic adrenoceptor theory: the characteristics of the effects of noradrenaline and phenoxybenzamine on stimulation-induced efflux of [3H]noradrenaline in vas deferens.

S Kalsner.   

Abstract

The effects of noradrenaline and phenoxybenzamine on the stimulation-induced efflux of 3H-transmitter were examined in guinea-pig vasa deferentia to assess how they conform to the expectations of presynaptic receptor theory. The vasa were stimulated transmurally with 0.5, 1.0, 3.0 and 10.0 Hz and with two different train lengths (10 and 50 pulses), in the presence of either the agonist or the antagonist. Noradrenaline (3 X 10(-7) M) depressed the stimulation-induced overflow of tritium by about 60% at each test frequency with 10 pulses and about 30% with 50 pulses, except at 0.5 Hz. Phenoxybenzamine (3 X 10(-5) M) increased the efflux of tritium to a diminishing extent with increasing frequency, with both the 10 and 50 pulses, and the effect was not sensitive to train length. The finding that the effect of phenoxybenzamine decreased with frequency and that of noradrenaline was essentially independent of frequency suggests that these compounds do not function as agonist and antagonist at a presynaptic adrenoceptor regulating transmitter output. Further, the distinctly different profiles of effect for noradrenaline and phenoxybenzamine, with frequency and train length, raises the possibility that they do not have a common mechanism or site of action in achieving their effects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6101347

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  15 in total

1.  One hundred years of adrenaline: the discovery of autoreceptors.

Authors:  M R Bennett
Journal:  Clin Auton Res       Date:  1999-06       Impact factor: 4.435

2.  Proceedings of the British Pharmacological Society. 16--18th December, 1980.

Authors: 
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

3.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

4.  Evidence against the unitary hypothesis of agonist and antagonist action at presynaptic adrenoceptors.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

5.  The role of calcium in the effects of noradrenaline and phenoxybenzamine on adrenergic transmitter release from atria: no support for negative feedback of release.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

6.  Stimulation-evoked release of [3H]-noradrenaline by 1, 10 or 100 pulses and its modification through presynaptic alpha 2-adrenoceptors.

Authors:  I Marshall
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

7.  A hypothesis to explain the presynaptic effects of adrenoceptor antagonists.

Authors:  S Kalsner; M Quillan
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

8.  Further study of prerequisites for the enhancement by alpha-adrenoceptor antagonists of the release of noradrenaline.

Authors:  N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

9.  Yohimbine and prolongation of stimulation pulse duration alter similarly 3H-transmitter efflux in heart: an alternative to the negative feedback hypothesis.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

10.  The effects of yohimbine on presynaptic and postsynaptic events during sympathetic nerve activation in cattle iris: a critique of presynaptic receptor theory.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.